Do preoperative pancreatic computed tomography attenuation index and enhancement ratio predict pancreatic fistula after pancreaticoduodenectomy?

Table 1 Comparison of demographic, clinical and preoperative radiological parameters between patients with and without clinically relevant postoperative pancreatic fistula

Parameter	CR-POPF, n = 18	No CR-POPF, n = 43	P value
Age in yr, mean ± SD	53.7 ± 10.8	54.7 ± 11.5	0.746
Sex, n (%)
Male	10 (55.6)	28 (65.1)	0.567
Female	8 (44.4)	15 (34.9)
BMI in kg/m2, mean ± SD	21.1 ± 4.4	20.1 ± 3.9	0.388
Weight loss, n (%)	15 (83.3)	32 (74.4)	0.525
Comorbidities, n (%)	11 (61.1)	22 (51.2)	0.578
Hemoglobin in gm%, mean ± SD	10.7 ± 1.4	10.8 ± 1.5	0.735
Preoperative serum bilirubin (mg/dL), median (IQR)	2 (1.8-6)	3 (1-7)	0.848
Preoperative biliary drainage, n (%)	10 (55.6)	22 (51.2)	0.786
Pancreatic attenuation index, mean ± SD	0.8 ± 0.2	0.8 ± 0.2	0.741
Pancreatic enhancement ratio, mean ± SD	0.6 ± 0.2	0.8 ± 0.4	0.006

CR-POPF: Clinically relevant postoperative pancreatic fistula; gm: Gram; IQR: Inter quartile range; SD: Standard deviation.